BIOTRICITY INC.: Ionic Ventures, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Ionic Ventures, LLC amended its Schedule 13G stake filing for Biotricity Inc., disclosing the change under SEC accession number 0001753926-26-002112. The filing updates the investor's previously reported ownership position in the medical device maker. Schedule 13G amendments are typically filed by passive investors when their holdings cross or adjust past the 5% threshold, though the headline did not specify the exact stake size or percentage change. The update matters because it signals a shift in a significant institutional holder's position in Biotricity. Investors will watch for the full filing details, including the reported share count and ownership percentage, to gauge Ionic Ventures' current influence on the stock.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
BiOtricity Inc., Ionic Ventures, LLC